Mundipharma Strikes Deal For Prestige's Trastuzumab

 
• By Dave Wallace

Mundipharma has struck a deal with Prestige BioPharma for rights to the Singapore-based firm’s biosimilar trastuzumab in selected European markets.

Trees_Puzzle
Mundipharma Wants To Be ‘Partner Of Choice’ In Europe • Source: Shutterstock

More from Deals

More from Business